Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
Tóm tắt
Từ khóa
Tài liệu tham khảo
Scadding Glenis, 2020, Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement, World Allergy Organ J, 13, 100124, 10.1016/j.waojou.2020.100124
2020, Coronavirus disease 2019 in children - United States, february 12-april 2, 2020, MMWR Morb Mortal Wkly Rep, 69, 422, 10.15585/mmwr.mm6914e4
He, 2020, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nat Med, 26, 672, 10.1038/s41591-020-0869-5
Bousquet, 2020
Minshall, 1998, Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis, Otolaryngol Head Neck Surg, 118, 648
Holmberg, 1986, Influence of topical beclomethasone dipropionate suspension on human nasal mucociliary activity, Eur J Clin Pharmacol, 30, 625, 10.1007/BF00542425
Halpin, 2020, Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective, Eur Respir J, 10.1183/13993003.01009-2020
Halpin, 2020, Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?, Lancet Respir Med, 8, 436, 10.1016/S2213-2600(20)30167-3
Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print, 2020 Feb 19], Allergy
Zhang, 2014, Prevalence of allergic rhinitis in China allergy asthma, Immunol Res, 6, 105
Istituto Superiore di Sanità
Canonica, 2014, Sublingual immunotherapy: world Allergy Organization position paper 2013 update, World Allergy Org J, 7, 6, 10.1186/1939-4551-7-6